Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

68399 Press Releases
DateTitleCompany
15 Dec 14 Ophthotech Added to NASDAQ Biotechnology Index Ophthotech Corporation,
Published by
Business Wire
15 Dec 14 Cerulean Announces Completion of Enrollment of a Phase 1b/2 Study of CRLX101 in Combination with Avastin® in Relapsed Renal Cell Carcinoma Cerulean Pharma Inc.,
Published by
Business Wire
15 Dec 14 David Altshuler M.D. Ph.D. Joins Vertex as Executive Vice President of Global Research and Chief Scientific Officer Vertex Pharmaceuticals Incorporated,
Published by
Business Wire
15 Dec 14 Microchips Biotech Inc. Completes Development and Clinical Demonstration of Proprietary Drug Delivery Platform and Advances Commercialization Efforts in Diabetes Contraception and Osteoporosis Microchips Biotech, Inc.,
Published by
Business Wire
15 Dec 14 Baxter to Divest Vero Cell Vaccines Platform to Nanotherapeutics Baxter International Inc.,
Published by
Business Wire
15 Dec 14 Seattle Researchers are a Significant Step Closer to an HIV Vaccine Seattle Biomedical Research Institute,
Published by
Business Wire
15 Dec 14 Annexon Bioscience Closes $34M Series A-1 Funding for Novel Approach to Neurodegenerative and Autoimmune Diseases Annexon Bioscience,
Published by
Business Wire
15 Dec 14 Shaun T's New INSANITY MAX:30 Introduces Ground-Breaking "Max Out Training" Method To Eliminate Plateaus And Maximize Results THE BRAND AMP,
Published by
PR Newswire
15 Dec 14 Novogen Provides Update On Progress Of Cantrixil Into The Clinic NOVOGEN LTD/PRN ASIA,
Published by
PR Newswire
15 Dec 14 Zimmer Holdings Inc. Announces Quarterly Dividend for Fourth Quarter of 2014 ZIMMER HOLDINGS,
Published by
PR Newswire
15 Dec 14 Abbott Commences Tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022 ABBOTT LABORATORIES,
Published by
PR Newswire
15 Dec 14 Enanta Pharmaceuticals Added to the NASDAQ Biotechnology Index Enanta Pharmaceuticals, Inc.,
Published by
Business Wire
15 Dec 14 Tetraphase Pharmaceuticals Added to NASDAQ Biotechnology Index Tetraphase Pharmaceuticals, Inc.,
Published by
Business Wire
15 Dec 14 Atox Bio Announces Appointment of Biotech Veteran Daniel D. Burgess as Chairman of the Board Atox Bio,
Published by
Business Wire
15 Dec 14 Akebia Therapeutics Inc. Added to NASDAQ Biotechnology Index Akebia Therapeutics, Inc.,
Published by
Business Wire
15 Dec 14 €6 Million in New Capital and New CEO for Cristal Therapeutics Cristal Therapeutics,
Published by
Business Wire
15 Dec 14 Bruker Introduces BioScope Resolve High-Resolution BioAFM System Bruker Corporation,
Published by
Business Wire
15 Dec 14 Arrowhead Files IND for RNAi Therapeutic ARC-520 to Begin Phase 2b Multiple-Dose Studies in Chronic Hepatitis B Patients Arrowhead Research Corporation,
Published by
Business Wire
15 Dec 14 Sophiris Bio Reports Administrative Interim Analysis for the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia Sophiris Bio Inc.,
Published by
Business Wire
15 Dec 14 New York’s Northern Medical Specialists Selects eClinicalWorks eClinicalWorks,
Published by
Business Wire
15 Dec 14 Acceleron Pharma Added to NASDAQ Biotechnology Index Acceleron Pharma,
Published by
Business Wire
15 Dec 14 Dicerna R&D Update Webcast Reminder Dicerna Pharmaceuticals, Inc.,
Published by
Business Wire
15 Dec 14 Insmed Appoints Myrtle Potter to its Board of Directors Insmed Incorporated,
Published by
Business Wire
15 Dec 14 Ignyta Announces Amendment to License Agreement with Nerviano Ignyta, Inc.,
Published by
Business Wire
15 Dec 14 Complexa Initiates Phase 1B Study of CXA-10 in Acute Kidney Injury Complexa, Inc.,
Published by
Business Wire
15 Dec 14 Philippe C. Bishop MD to Join Gilead as Senior Vice President Hematology and Oncology Therapeutics Gilead Sciences, Inc.,
Published by
Business Wire
15 Dec 14 Companion Diagnostics in Personalized Medicine and Cancer Therapy RESEARCH AND MARKETS,
Published by
PR Newswire
15 Dec 14 Second Part of the Glaucoma Phase II study has been Approved in a European Country CAN-FITE BIOPHARMA, LTD./KCSA STRATEGIC COMMUNICATIONS,
Published by
PR Newswire
15 Dec 14 Volcano Announces 1000th System Activated with its iFR® (instant wave-Free Ratio™) Modality Worldwide VOLCANO CORPORATION,
Published by
PR Newswire
15 Dec 14 Synageva BioPharma Announces Active Investigational New Drug Application For SBC-103 For The Treatment Of Mucopolysaccharidosis IIIB SYNAGEVA BIOPHARMA Corp.,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.